CD19联合CD22 CAR-T细胞疗法在异体移植后复发的B-ALL患者中的五年疗效

{"title":"CD19联合CD22 CAR-T细胞疗法在异体移植后复发的B-ALL患者中的五年疗效","authors":"Shuangyou Liu, L. An, Zhichao Yin, Yue-hui Lin, Zhuojun Lin, B. Deng, Xinjian Yu, Q. Zheng, Defeng Zhao, Tong Wu, Alex H Chang, Chunrong Tong","doi":"10.33590/emjhematol/bofe4319","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":509115,"journal":{"name":"EMJ Hematology","volume":"67 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Five-year Outcome of CD19 Combined With CD22 CAR-T Cell Therapy in Patients With B-ALL Relapsed After Allo-transplantation\",\"authors\":\"Shuangyou Liu, L. An, Zhichao Yin, Yue-hui Lin, Zhuojun Lin, B. Deng, Xinjian Yu, Q. Zheng, Defeng Zhao, Tong Wu, Alex H Chang, Chunrong Tong\",\"doi\":\"10.33590/emjhematol/bofe4319\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":509115,\"journal\":{\"name\":\"EMJ Hematology\",\"volume\":\"67 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMJ Hematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33590/emjhematol/bofe4319\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjhematol/bofe4319","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}